Furthermore, IL-32γ overexpression can promote the growth and apoptosis of lung cancer stem cells, but this promotive effect can be reversed by ITGAV, indicating that the STAT5 pathway mediated by ITGAV can promote the growth of lung cancer stem cells (Lee et al., 2019). This evidence concerns the gene ITGAV and lung carcinoma.